17-58270847-C-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_000250.2(MPO):āc.2047G>Cā(p.Glu683Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000477 in 1,613,310 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000250.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPO | NM_000250.2 | c.2047G>C | p.Glu683Gln | missense_variant | 12/12 | ENST00000225275.4 | NP_000241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPO | ENST00000225275.4 | c.2047G>C | p.Glu683Gln | missense_variant | 12/12 | 1 | NM_000250.2 | ENSP00000225275.3 |
Frequencies
GnomAD3 genomes AF: 0.00246 AC: 374AN: 152180Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000613 AC: 154AN: 251266Hom.: 1 AF XY: 0.000405 AC XY: 55AN XY: 135876
GnomAD4 exome AF: 0.000271 AC: 396AN: 1461012Hom.: 5 Cov.: 30 AF XY: 0.000222 AC XY: 161AN XY: 726818
GnomAD4 genome AF: 0.00246 AC: 374AN: 152298Hom.: 1 Cov.: 32 AF XY: 0.00226 AC XY: 168AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The MPO p.E683Q variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs35702888) and in control databases in 234 of 282640 chromosomes (1 homozygous) at a frequency of 0.0008279 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 213 of 24936 chromosomes (freq: 0.008542), Other in 4 of 7220 chromosomes (freq: 0.000554), Latino in 15 of 35440 chromosomes (freq: 0.000423) and European (non-Finnish) in 2 of 128998 chromosomes (freq: 0.000016), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or South Asian populations. The p.Glu683 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and one of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at